Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Body Count Linked to GSK Vaccine Trial Rises
- Fourteen children have now died during a pneumonia vaccine trial run by GlaxoSmithKline in Argentina, according to the U.K.'s Daily Mail. Argentine authorities are investigating. GSK says the deaths are not linked to the tests. This issue first emerged for GSK in July, when TradingMarkets.com reported that...
- Blog posts 2008-08-18
Additional Resources
- Prana Completes Clinical Phase Of Alzheimer's Drug Trial
- Prana Biotechnology Limited's (NASDAQ: PRNAF; ASX: PBT) executive chairman, Geoffrey Kempler, has reported that the company has completed the clinical phase of the its Alzheimer's disease drug trial in Australia. Kempler expressed hope that the landmark trial, the first of several planned by the company, will demonstrate successful "proof...
- Research articles 2002-03-01
- Drug trial victims show signs of improvement, two still critical
- LONDON AFP — Two men who fell critically ill after taking part in a drug trial in London have shown signs of responding to treatment, while four fellow patients are now fully conscious, doctors said. All six men, however, remain in intensive care at Northwick Park Hospital in northwest...
- Research articles 2006-03-17
- Drug trial victims continue slight improvement
- LONDON AFP — Two men who fell critically ill after taking part in a drug trial in London showed further slight improvement, the hospital treating them revealed. "The very early signs of improvement seen on Friday have continued, but we must make it clear that because of their complex...
- Research articles 2006-03-18
- Genzyme Expands Overseas Operations and CytRx Cleared for Phase II Drug Trial.
- M2 PRESSWIRE-23 September 2005-US Financial Network: Genzyme Expands Overseas Operations and CytRx Cleared for Phase II Drug TrialC1994-2005 M2 COMMUNICATIONS LTD RDATE:23092005 City of Industry, CA - Biotechnology industry news provided by Financial News USA (OTC: FNWU) Genzyme Corp. has officially...
- Research articles 2005-09-23
- NEJM: Foreign Drug Trials Could Hurt U.S. Patients
- The increasing use of foreign drug trials may hurt U.S. patients because of genetic and environmental differences in overseas study subjects, a new study in the New England Journal of Medicine suggests. "Are trial results accurate and valid, and can they be extrapolated to other settings?" asks a team from...
- Blog posts 2009-02-19
- Simcere Shows Positive Data from Cancer Drug Trial
- ChinaBio Today submits: Simcere Pharma SCR reported that interim results from a Phase IV trial of its patented anti-cancer drug Endu showed the drug displayed both safety and efficacy. The data were in line with Endu’s Phase III trial. An anti-angiogenesis drug, Endu is a modified version of recombinant...
- External links 2008-09-03
- China Aoxing Wins OK for Narcotic Drug Trial
- ChinaBio Today submits: China Aoxing Pharmaceutical Company (CAXG.OB) received SFDA approval to begin a clinical trial of Tilidine/Naloxone capsules, a narcotic drug for moderate to severe pain. The drug is given to alleviate cancer and post-surgical pain. China Aoxing plans to begin the clinical trial by the end of...
- External links 2009-09-18
- Access Pharma to Launch U.S. Cancer Drug Trial in China
- ChinaBio Today submits: Access Pharmaceuticals, Inc. (ACCP.OB) of Texas revealed plans for a clinical trial of its solid tumor cancer drug, ProLindac, in China. The trial will be conducted by Access Pharma’s China partner, Aosaikang Medicinal Group (ASK), a company that is also responsible for manufacturing scale-up of ProLindac....
- External links 2009-08-05
- New Drug Trial Protocol Approved for Nymox Prostate Drug; Nymox -NASDAQ: NYMX- NX-1207 Drug Treatment for Benign Prostatic Hyperplasia
- MAYWOOD, N.J. -- Nymox Pharmaceutical Corporation announced today that the new clinical trial protocol for the Company's investigational new drug NX-1207 for benign prostatic hyperplasia has been found acceptable by the FDA. The Company will be proceeding into pivotal U.S. Phase II testing of NX-1207.
- Research articles 2004-07-14
- German firm says sorry as drug trial victims fight for life
- LONDON AFP — A German drug company said it has apologised to the families of six men who were in hospital, two badly deformed and fighting for their lives, after a clinical trial in London went horribly wrong. Thomas Hanke, chief scientific officer at TeGenero, also insisted that the...
- Research articles 2006-03-15
- Firms behind horrific London drug trial defend conduct
- BOSTON, United States AFP — The US and German drug companies that ran a disastrous clinical trial in a London hospital defended their conduct after six men suffered horrific adverse reactions. Parexel International, the Boston company that ran the test facility in London's Northwick Park Hospital, said the trial...
- Research articles 2006-03-16
- Update on Phase II Trial: Clinical Phase Concluded.
- Jan 22, 2002 Australian Stock Exchange Announcements ABIX via COMTEX -- Prana Biotechnology, an Australian biotechnology firm, hopes to receive the results of a drug trial by April 2002. Geoffrey Kempler, the Executive Chairman of the company, reported on 22 January 2002 that the...
- Research articles 2002-01-22
- ApoCell to Conduct Studies in Support of Novel Pfizer Cancer Drug Trial
- HOUSTON -- ApoCell Inc. has been engaged by Pfizer, Inc. to support a Phase 1 clinical trial being conducted in three sites in the U.S. and abroad. ApoCell will use its target expression profile (TEP[TM]) technology along with immunohistochemistry to generate data to select those patients most likely to benefit...
- Research articles 2008-01-24
- Rockville-based Human Genome Sciences Inc. buoyed by drug trial
- Human Genome Sciences Inc. officials still are optimistic about a future late-stage human trial for the company's lupus drug candidate, though the compound recorded disappointing results in mid- stage trials.
- Research articles 2005-10-06
- Drug trial opens for inmate representing himself
- "I'm a career criminal basically. I'm not ashamed of who I am and what I did." --- MICHAEL MCELHINEY, on trial for drug charges By STEVE FRY The Capital-Journal Michael McElhiney told prospective jurors in U.S. District Court on Monday that he...
- Research articles 1999-09-28
- British drug trial: two patients remain 'critical'
- LONDON AFP — Two men remained critically ill after taking part in a disastrous drugs trial in London, the hospital treating them said. Four other men remained "seriously ill" after testing a cancer drug, but were showing signs of improvement, according to Ganesh Suntharalingam, Clinical Director of Intensive Care...
- Research articles 2006-03-19
- Seattle Biotechnology Firm to Sell Property, Cut Jobs, Finish Drug Trial.
- By Luke Timmerman, The Seattle Times Knight Ridder/Tribune Business News Nov. 14--NeoRx, an embattled veteran of Seattle biotechnology, has found a way to extend its life span by selling nearly $8 million worth of intellectual property, cutting about a dozen jobs and...
- Research articles 2002-11-14
- Stock Drops at Tarrytown, N.Y.-Based Regeneron on Obesity-Drug Trial Results.
- By Jeremy Boyer, Times Union, Albany, N.Y. Knight Ridder/Tribune Business News Apr. 1--A Tarrytown-based pharmaceutical company that employs about 225 people in East Greenbush lost more than half its market value Monday after releasing disappointing results from a clinical trial for ...
- Research articles 2003-04-01
- College Football: Arizona tight end faces drug trial.
- Dec 10, 2002 The Sports Network via COMTEX Cambridge, IL Sports Network - University of Arizona tight end Justin Levasseur will face trial on February 3 after being arrested with 87 pounds of marijuana. A judge also set a pretrial...
- Research articles 2002-12-11
- << Previous
- page 1 of 1
- Next >>
